Ibex Wealth Advisors acquired a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 11,827 shares of the conglomerate's stock, valued at approximately $2,715,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Fort Pitt Capital Group LLC raised its stake in shares of Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock valued at $66,194,000 after purchasing an additional 7,421 shares in the last quarter. Good Life Advisors LLC acquired a new position in Danaher during the third quarter worth about $217,000. ORG Partners LLC grew its holdings in Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock worth $636,000 after acquiring an additional 2,559 shares during the period. Harvest Portfolios Group Inc. grew its holdings in Danaher by 1.2% during the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock worth $56,233,000 after acquiring an additional 2,465 shares during the period. Finally, Stifel Financial Corp grew its holdings in Danaher by 1.3% during the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate's stock worth $235,583,000 after acquiring an additional 11,216 shares during the period. 79.05% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
DHR has been the topic of a number of research analyst reports. Scotiabank initiated coverage on Danaher in a report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 target price on the stock. Jefferies Financial Group lowered their target price on Danaher from $285.00 to $260.00 and set a "buy" rating on the stock in a report on Wednesday. StockNews.com cut Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, December 14th. KeyCorp lifted their price target on Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 23rd. Finally, Stifel Nicolaus lifted their price target on Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $278.00.
View Our Latest Report on Danaher
Danaher Stock Performance
DHR traded down $0.57 on Thursday, hitting $223.16. The company had a trading volume of 6,666,404 shares, compared to its average volume of 3,626,230. The company's fifty day moving average price is $235.89 and its 200 day moving average price is $253.45. Danaher Co. has a 1-year low of $221.34 and a 1-year high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The stock has a market cap of $161.19 billion, a price-to-earnings ratio of 42.59, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same period last year, the company posted $2.09 earnings per share. Equities analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.48%. Danaher's dividend payout ratio (DPR) is presently 20.61%.
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
